Selective novel inverse agonists for human GPR43 augment GLP-1 secretion
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Bi-Oh | - |
dc.contributor.author | Kim, Seong Heon | - |
dc.contributor.author | Kong, Gye Yeong | - |
dc.contributor.author | Kim, Da Hui | - |
dc.contributor.author | Kwon, Mi So | - |
dc.contributor.author | Lee, Su Ui | - |
dc.contributor.author | Kim, Mun-Ock | - |
dc.contributor.author | Cho, Sungchan | - |
dc.contributor.author | Lee, Sangku | - |
dc.contributor.author | Lee, Hyun-Jun | - |
dc.contributor.author | Han, Sang-Bae | - |
dc.contributor.author | Kwak, Young Shin | - |
dc.contributor.author | Lee, Sung Bae | - |
dc.contributor.author | Kim, Sunhong | - |
dc.date.accessioned | 2021-09-04T03:51:41Z | - |
dc.date.available | 2021-09-04T03:51:41Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2016-01-15 | - |
dc.identifier.issn | 0014-2999 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/89801 | - |
dc.description.abstract | GPR43/Free Fatty Acid Receptor 2 (FFAR2) is known to be activated by short-chain fatty acids and be coupled to G(i), and G(q), family of heterotrimeric G proteins. GPR43 is mainly expressed in neutrophils, adipocytes and enteroendocrine cells, implicated to be involved in inflammation, obesity and type 2 diabetes. However, several groups have reported the contradictory data about the physiological functions of GPR43, so that its roles in vivo remain unclear. Here, we demonstrate that a novel compound of pyrimidinecarboxamide class named as BTI-A-404 is a selective and potent competitive inverse agonist of human GPR43, but not the murine ortholog. Through structure-activity relationship (SAR), we also found active compound named as BTI-A-292. These regulators increased the cyclic AMP level and reduced acetate-induced cytoplasmic Ca2+ level. Furthermore, we show that they modulated the downstream signaling pathways of GPR43, such as ERK, p38 MAPK, and NF-kappa B. It was surprising that two compounds augmented the secretion of glucagon-like peptide 1 (GLP-1) in NCI-H716 cell line. Collectively, these novel and specific competitive inhibitors regulate all aspects of GPR43 signaling and the results underscore the therapeutic potential of them. (C) 2015 Elsevier B.V. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.subject | CHAIN FATTY-ACIDS | - |
dc.subject | PROTEIN-COUPLED RECEPTORS | - |
dc.subject | INFLAMMATORY RESPONSES | - |
dc.subject | ENTEROENDOCRINE CELLS | - |
dc.subject | PEPTIDE-1 SECRETION | - |
dc.subject | SPECIES ORTHOLOGS | - |
dc.subject | GUT MICROBIOTA | - |
dc.subject | BETA-ARRESTINS | - |
dc.subject | KAPPA-B | - |
dc.subject | ACTIVATION | - |
dc.title | Selective novel inverse agonists for human GPR43 augment GLP-1 secretion | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kwak, Young Shin | - |
dc.identifier.doi | 10.1016/j.ejphar.2015.12.010 | - |
dc.identifier.scopusid | 2-s2.0-84949758588 | - |
dc.identifier.wosid | 000368105100001 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF PHARMACOLOGY, v.771, pp.1 - 9 | - |
dc.relation.isPartOf | EUROPEAN JOURNAL OF PHARMACOLOGY | - |
dc.citation.title | EUROPEAN JOURNAL OF PHARMACOLOGY | - |
dc.citation.volume | 771 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 9 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | CHAIN FATTY-ACIDS | - |
dc.subject.keywordPlus | PROTEIN-COUPLED RECEPTORS | - |
dc.subject.keywordPlus | INFLAMMATORY RESPONSES | - |
dc.subject.keywordPlus | ENTEROENDOCRINE CELLS | - |
dc.subject.keywordPlus | PEPTIDE-1 SECRETION | - |
dc.subject.keywordPlus | SPECIES ORTHOLOGS | - |
dc.subject.keywordPlus | GUT MICROBIOTA | - |
dc.subject.keywordPlus | BETA-ARRESTINS | - |
dc.subject.keywordPlus | KAPPA-B | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordAuthor | GPR43 | - |
dc.subject.keywordAuthor | SCFA | - |
dc.subject.keywordAuthor | Inverse agonist | - |
dc.subject.keywordAuthor | BTI-A-404 | - |
dc.subject.keywordAuthor | BTI-A-202 | - |
dc.subject.keywordAuthor | GLP-1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.